Try it
PSM · Communicable diseases: interpreting a malaria rapid test
Sample itemA man treated with artemisinin combination therapy for falciparum malaria 10 days earlier is afebrile, yet an HRP-2 based rapid test is positive at follow up. What is the best interpretation?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
A. Persistent antigenaemia, to be confirmed by microscopy before calling it failure
HRP-2 antigen can persist in blood for weeks after parasites are cleared, so a positive test in a recovered patient is not proof of failure. Microscopy should confirm the presence of parasites. Rapid tests based on HRP-2 are therefore unsuitable for monitoring treatment response.
Option by option
A. Persistent antigenaemia, to be confirmed by microscopy before calling it failure (correct)
Correct. HRP-2 persists after clearance and microscopy decides.
B. Definite treatment failure needing injectable artesunate
Failure cannot be diagnosed from antigen alone in an afebrile patient.
C. Mixed infection with Plasmodium vivax
HRP-2 is specific for falciparum, not vivax.
D. Laboratory error as the test cannot detect falciparum antigen
HRP-2 is the very antigen that detects falciparum malaria.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: